FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to parenteral formulations for administering certain derivatives formed by 1-β-D-arabinofuranosylcytosine (cytarabine) and saturated and monounsaturated long-chain fatty acids (elacytarabine).
EFFECT: present invention refers to the parenteral pharmaceutical composition enabling administering therapeutically effective doses of the above derivatives, which increases patient's compliance with cancer treatment, as well as to a method for producing the same.
15 cl, 6 ex, 5 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
| ANTAGONISTS NEUROKININ-1 COMPOSITIONS FOR INTRAVENOUS INTRODUCTION | 2010 |
|
RU2642234C2 |
| LIPOSOMAL PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION | 1995 |
|
RU2160099C2 |
| PHARMACEUTICAL COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF INCREASE OF AN ACTIVE SUBSTANCE BIOLOGICAL AVAILABILITY USING THIS COMPOSITION | 1991 |
|
RU2104715C1 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
| COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | 2009 |
|
RU2522977C2 |
| INHALATION FATTY EMULSION | 1999 |
|
RU2212230C2 |
| COMPOSITIONS AND WAYS OF PHARMACOLOGICAL AGENTS DELIVERY | 2003 |
|
RU2361615C2 |
| THERAPEUTIC APPLICATION OF KRILL OIL | 2012 |
|
RU2625760C2 |
